Sfoglia per Autore
Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial
2012 Mancardi, GL; Sormani, MP; Gualandi, F; Saiz, A; Carreras, E; Merelli, E; Donelli, A; Lugaresi, A; Di Bartolomeo, P; Rambaldi, A; Rottoli, M; Amato, MP; Massacesi, L; Di Gioia, M; Vuolo, L; Curro, D; Roccatagliata, L; Capello, E; Uccelli, A; Iacopino, P; Aguglia, U; Filippi, M; Saccardi, R
Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis
2012 Mancardi, GL; Sormani, MP; Gualandi, F; Saiz, A; Carreras, E; Merelli, E; Donelli, A; Lugaresi, A; Di Bartolomeo, P; Rottoli, M; Rambaldi, A; Amato, MP; Massacesi, L; Vuolo, L; Curro, D; Roccatagliata, L; Filippi, M; Russo, C; Iacopino, P; Saccardi, R
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience
2012 Mancardi, G.L.; Sormani, M.P.; Di Gioia, M.; Vuolo, L.; Gualandi, F.; Amato, M.P.; Capello, E.; Currò, D.; Uccelli, A.; Bertolotto, A.; Gasperini, C.; Lugaresi, A.; Merelli, E.; Meucci, G.; Motti, L.; Tola, M.R.; Scarpini, E.; Repice, A.M.; Massacesi, L.; Saccardi, R.
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies.
2015 Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A. M.; Mechi, C.; M., Grammatico; Prisco, D.; Silvestri, E.; Barilaro, A.; Emmi, L.; Massacesi, L.
Leptomeningeal and parenchymal MS lesions through MRI at different magnetic fields.
2015 Vuolo L
Efficiency of FLAIR* at 1.5T, 3T, and 7T for detecting perivenular lesions in multiple sclerosis (MS)
2015 Vuolo, L; Dewey, B; Sati, P; Massacesi, L; Reich, DS
Imaging perivenular distribution can differentiate MS from CNS vasculitis.
2015 Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A. M.; Mechi, C.; Grammatico Di Tullio, M.; Silvestri, E.; Barilaro, A.; Prisco, D.; Emmi, L.; Massacesi, L.
Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume
2015 Bandieri, L; Vuolo, L; Repice, AM; Grammatico, M; Mechi, C; Massacesi, L
Leptomeningeal enhancement analysis in diagnostic clinical setting
2015 Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Forci, B; Massacesi, L
Comparison of azathioprine and of beta interferon efficacy on measures of brain damage evaluated by MRI in relapsing-remitting multiple sclerosis
2016 Massacesi, L; Grammatico, M; Vuolo, L; Barilaro, A; Benedetti, MD; La Mantia, L; Milanese, C; Repice, AM; Solari, A; Tedeschi, G; Filippini, G
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases.
2016 Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A.; Magnani, E.; Spagni, G.; Prisco, D.; Silvestri, E.; Barilaro, A.; Sati, P.; Reich, D.; Massacesi, L.
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis.
2017 M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L.
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis.
2017 M., Grammatico; Dallagiacoma, S.; Lorenzoni, L.; Carlucci, G.; Repice, A. M.; Mechi, C.; Magnani, E.; Vuolo, L.; Fainardi, E.; Massacesi, L.
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination
2018 Grammatico, M; Carlucci, G; Dallagiacoma, S; Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L
Central vein sign differentiates MS from CNS inflammatory vasculopathies.
2018 Maggi, P; Absinta, M; M, Grammatico; Vuolo, L; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, Am; Emmi, L; Prisco, D; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, Ds; Filippi, M; Massacesi, L.
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series
2021 Fonderico, Mattia; Biagioli, Tiziana; Lanzilao, Luisa; Bellinvia, Angelo; Fratangelo, Roberto; Pastò, Luisa; Prestipino, Elio; Razzolini, Lorenzo; Tudisco, Laura; Ginestroni, Andrea; Vuolo, Luisa; Fainardi, Enrico; Ballerini, Clara; Portaccio, Emilio; Amato, Maria Pia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Autologous Stem Cell Transplantation International Multiple Sclerosis (ASTIMS) trial: a randomised, phase II, controlled, multicentre trial | 2012 | Mancardi, GL; Sormani, MP; Gualandi, F; Saiz, A; Carreras, E; Merelli, E; Donelli, A; Lugaresi, A; Di Bartolomeo, P; Rambaldi, A; Rottoli, M; Amato, MP; Massacesi, L; Di Gioia, M; Vuolo, L; Curro, D; Roccatagliata, L; Capello, E; Uccelli, A; Iacopino, P; Aguglia, U; Filippi, M; Saccardi, R | |
| Preliminary results of ASTIMS, a prospective randomised Phase II EBMT trial on autologous HSCT in poor prognosis Multiple Sclerosis | 2012 | Mancardi, GL; Sormani, MP; Gualandi, F; Saiz, A; Carreras, E; Merelli, E; Donelli, A; Lugaresi, A; Di Bartolomeo, P; Rottoli, M; Rambaldi, A; Amato, MP; Massacesi, L; Vuolo, L; Curro, D; Roccatagliata, L; Filippi, M; Russo, C; Iacopino, P; Saccardi, R | |
| Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: The Italian multi-centre experience | 2012 | Mancardi, G.L.; Sormani, M.P.; Di Gioia, M.; Vuolo, L.; Gualandi, F.; Amato, M.P.; Capello, E.; Currò, D.; Uccelli, A.; Bertolotto, A.; Gasperini, C.; Lugaresi, A.; Merelli, E.; Meucci, G.; Motti, L.; Tola, M.R.; Scarpini, E.; Repice, A.M.; Massacesi, L.; Saccardi, R. | |
| Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. | 2015 | Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A. M.; Mechi, C.; M., Grammatico; Prisco, D.; Silvestri, E.; Barilaro, A.; Emmi, L.; Massacesi, L. | |
| Leptomeningeal and parenchymal MS lesions through MRI at different magnetic fields. | 2015 | Vuolo L | |
| Efficiency of FLAIR* at 1.5T, 3T, and 7T for detecting perivenular lesions in multiple sclerosis (MS) | 2015 | Vuolo, L; Dewey, B; Sati, P; Massacesi, L; Reich, DS | |
| Imaging perivenular distribution can differentiate MS from CNS vasculitis. | 2015 | Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A. M.; Mechi, C.; Grammatico Di Tullio, M.; Silvestri, E.; Barilaro, A.; Prisco, D.; Emmi, L.; Massacesi, L. | |
| Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume | 2015 | Bandieri, L; Vuolo, L; Repice, AM; Grammatico, M; Mechi, C; Massacesi, L | |
| Leptomeningeal enhancement analysis in diagnostic clinical setting | 2015 | Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Forci, B; Massacesi, L | |
| Comparison of azathioprine and of beta interferon efficacy on measures of brain damage evaluated by MRI in relapsing-remitting multiple sclerosis | 2016 | Massacesi, L; Grammatico, M; Vuolo, L; Barilaro, A; Benedetti, MD; La Mantia, L; Milanese, C; Repice, AM; Solari, A; Tedeschi, G; Filippini, G | |
| MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. | 2016 | Vuolo, L.; Emmi, G.; Carlucci, G.; Repice, A.; Magnani, E.; Spagni, G.; Prisco, D.; Silvestri, E.; Barilaro, A.; Sati, P.; Reich, D.; Massacesi, L. | |
| Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. | 2017 | M, Grammatico; Carlucci, G; Dalla Giacoma, S; Vuolo, L; Repice, Am; Mechi, C; Magnani, E; Barilaro, A; Fainardi, E; Massacesi, L. | |
| Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. | 2017 | M., Grammatico; Dallagiacoma, S.; Lorenzoni, L.; Carlucci, G.; Repice, A. M.; Mechi, C.; Magnani, E.; Vuolo, L.; Fainardi, E.; Massacesi, L. | |
| The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination | 2018 | Grammatico, M; Carlucci, G; Dallagiacoma, S; Vuolo, L; Repice, AM; Mechi, C; Magnani, E; Barilaro, A; Massacesi, L | |
| Central vein sign differentiates MS from CNS inflammatory vasculopathies. | 2018 | Maggi, P; Absinta, M; M, Grammatico; Vuolo, L; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, Am; Emmi, L; Prisco, D; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, Ds; Filippi, M; Massacesi, L. | |
| Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series | 2021 | Fonderico, Mattia; Biagioli, Tiziana; Lanzilao, Luisa; Bellinvia, Angelo; Fratangelo, Roberto; Pastò, Luisa; Prestipino, Elio; Razzolini, Lorenzo; Tudisco, Laura; Ginestroni, Andrea; Vuolo, Luisa; Fainardi, Enrico; Ballerini, Clara; Portaccio, Emilio; Amato, Maria Pia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile